Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Quetiapine on the Drug Abuse Patterns of Addicted Schizophrenic Patients

NCT00295412 is registered in ClinicalTrials.gov with Université de Montréal as lead sponsor.

NCT NCT00295412
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00295412 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Quetiapine on the Drug Abuse Patterns of Addicted Schizophrenic Patients
Lead sponsor
Université de Montréal
Phase
Phase 4
Overall status
Completed
Start date
Not reported
Completion date
Not reported
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia, substance use disorders